Antibody Protein ELISA Kit from MyBioSource header Telephone 1.858.633.0165          
Fax 1.858.633.0166    Email 
menu1 Home Products Ordering Company Help menu7
   MyBioSource  rightarrow Blog  rightarrow OR4F29 sirna  rightarrow LOG IN  rightarrow MY ACCOUNT  rightarrow CART CONTENTS  rightarrow CHECKOUT 
horiz bar
MyBioSource Blogs moreseparator
 • NTF3 sirna blog
 • Mouse Anti-Mouse I-Ek secondary antibody blog
 • PRDX2 recombinant protein blog
 • WP1130 biochemical blog
 • IFNG elisa kit blog
 • anti-Kanamycin antibody blog
 • NPPB shrna blog
 • STAM2 blocking peptide blog
 • anti-CD80 antibody blog
 • anti-GPR115 antibody blog
 • anti-ZNF37A antibody blog
 • SPINT1 sirna blog
 • ADPN elisa kit blog
 • anti-Baboon (fruit fly) antibody blog
 • anti-M-4 Muscarinic receptor antibody blog
 • KLRA1 blocking peptide blog
 • COR elisa kit blog
 • UHRF1BP1L sirna blog
 • anti-CD169 antibody blog
 • ADAM8 sirna blog
Blog Categories separator
 • Assay Kit Blogs
 • Biochemical Blogs
 • cDNA Clone Blogs
 • Monoclonal Antibody Blogs
 • Polyclonal Antibody Blogs
 • Rec/Purified Protein Blogs
 • Popular Product Blogs
Our Best Sellers moreseparator
 • ABCB1 siRNA
 • 5-lipoxygenase (5-LO-LOX) ELISA Kit
 • Vimentin Antibody
 • a glutathione S transferases (A GST) ELISA Kit
 • STAT4-Y693 Antibody
 • 25-Dihydroxy Vitamin D3 (25-DVD3) ELISA Kit
 • anti-prothrombins antibodies (aPT1 - aPT2) ELISA Kit
 • Extracellular calcium-sensing receptor (CASR) ELISA Kit
 • SNAI2 Antibody
 • SLC30A6 Antibody
 • C-reactive protein, pentraxin-related (CRP) ELISA Kit
 • cMyc Antibody
 • leptin Recombinant Protein
 downarrow more ...

OR4F29 sirna product blog

Posted on 2018-03-13 00:56:12 by mybiosource_staff
Share it on ...     
Tags: siRNA; OR4F29; OR4F29 sirna;
The OR4F29 or4f3 (Catalog #MBS8208617) is a siRNA produced from Synthetic and is intended for research purposes only. The product is available for immediate purchase. The OR4F29 siRNA (Human) reacts with Human and may cross-react with other species as described in the data sheet. MyBioSource\'s OR4F29 can be used in a range of immunoassay formats including, but not limited to, RNA Interference (RNAi). Researchers should empirically determine the suitability of the OR4F29 or4f3 for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.

The OR4F29 or4f3 product has the following accession number(s) (GI #119943152) (NCBI Accession #NP_001005221.2) (Uniprot Accession #Q6IEY1). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.

To buy or view more detailed product information and pricing, please click on the technical datasheet page below:

siRNA to inhibit OR4F29 expression using RNA interference.

OR4F29 or4f3

Quality Control: Oligonucleotide synthesis is monitored base by base through trityl analysis to ensure appropriate coupling efficiency. The oligo is subsequently purified by affinity-solid phase extraction. The annealed RNA duplex is further analyzed by mass spectrometry to verify the exact composition of the duplex. Each lot is compared to the previous lot by mass spectrometry to ensure maximum lot-to-lot consistency.
Directions for Use: We recommends transfection with 100 nM siRNA 48 to 72 hours prior to cell lysis. Before resuspending, briefly centrifuge the tube to ensure the lyophilized siRNA is at the bottom of the tube. Resuspend the siRNA oligos to an appropriate concentration with DEPC water. For each vial, suitable for 250 transfections in 24 well plate (20 pmol for each well).
Components: We offer pre-designed sets of 3 different target-specific siRNA oligo duplexes of human OR4F29 gene. Each vial contains 5 nmol of lyophilized siRNA. The duplexes can be transfected individually or pooled together to achieve knockdown of the target gene, which is most commonly assessed by qPCR or western blot. Our siRNA oligos are also chemically modified (2\'-OMe) at no extra charge for increased stability and enhanced knockdown in vitro and in vivo. The following patways have been known to be associated with this gene.
horiz bar
 SSL   Follow us on Facebook Follow us onTwitter Follow us on Google Plus Connect us on LinkedIn Subscribe to our RSS Feed for latest products and special promotions